Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:NA-Gly 7:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004035 AN006673 Serum Metabolites at Defined Stages of Liver Disease Liver Mouse Liver disease University of Texas Health Science Center at Houston LC-MS
ST003970 AN006532 Comprehensive multiplatform mass spectrometry-based metabolomics unveils insights into Babesia divergens metabolism. Erythrocytes Human Parasitic infection CEMBIO GC-MS/LC-MS/CE-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003790 AN006230 Fecal metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody Feces Mouse Cancer Princeton University LC-MS
ST003789 AN006228 Serum metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody Blood Mouse Cancer Princeton University LC-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Human Cancer Universitätsspital Zürich MALDI-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Mouse Cancer Universitätsspital Zürich MALDI-MS
ST003639 AN005976 Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells Cultured cells Human Cancer Portuguese Oncology Institute of Porto (IPO-Porto) LC-MS
ST003639 AN005977 Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells Cultured cells Human Cancer Portuguese Oncology Institute of Porto (IPO-Porto) LC-MS
ST003160 AN005185 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
  logo